Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,478
archived clinical trials in
Smoking Cessation

A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated:  11/27/2017
West Central Behavioral Health
mi
from
Claremont, NH
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated: 11/27/2017
West Central Behavioral Health
mi
from
Claremont, NH
Click here to add this to my saved trials
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated:  11/27/2017
Riverbend Community Mental Health Center
mi
from
Concord, NH
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated: 11/27/2017
Riverbend Community Mental Health Center
mi
from
Concord, NH
Click here to add this to my saved trials
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated:  11/27/2017
Mental Health Center of Greater Manchester
mi
from
Manchester, NH
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated: 11/27/2017
Mental Health Center of Greater Manchester
mi
from
Manchester, NH
Click here to add this to my saved trials
Effect of Galantamine on Smoking Abstinence
The Effect of the Acetylcholinesterase Inhibitor, Galantamine, on Short-term Abstinence
Status: Enrolling
Updated:  11/27/2017
Center for Interdisciplinary Research on Nicotine Addiction, School of Medicine, University of Pennsylvania
mi
from
Philadelphia, PA
Effect of Galantamine on Smoking Abstinence
The Effect of the Acetylcholinesterase Inhibitor, Galantamine, on Short-term Abstinence
Status: Enrolling
Updated: 11/27/2017
Center for Interdisciplinary Research on Nicotine Addiction, School of Medicine, University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Quit and Fit: A Tobacco Cessation and Energy Balance Pilot for African Americans
Quit and Fit: A Tobacco Cessation and Energy Balance Pilot for African Americans
Status: Enrolling
Updated:  11/27/2017
Georgetown University Lombardi community site office
mi
from
Washington,
Quit and Fit: A Tobacco Cessation and Energy Balance Pilot for African Americans
Quit and Fit: A Tobacco Cessation and Energy Balance Pilot for African Americans
Status: Enrolling
Updated: 11/27/2017
Georgetown University Lombardi community site office
mi
from
Washington,
Click here to add this to my saved trials
Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects
Open-Label, Multicenter Study Evaluating the Safety and Efficacy of the Nicotine Replacement Therapy Chrono Quit Smoking Solution (CQSS2) System (21mg) Compared to the NicoDerm® CQ® Patch (21mg) for Smoking Cessation in Treatment Seeking Subjects
Status: Enrolling
Updated:  11/30/2017
Coastal Clinical Research Inc
mi
from
Mobile, AL
Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects
Open-Label, Multicenter Study Evaluating the Safety and Efficacy of the Nicotine Replacement Therapy Chrono Quit Smoking Solution (CQSS2) System (21mg) Compared to the NicoDerm® CQ® Patch (21mg) for Smoking Cessation in Treatment Seeking Subjects
Status: Enrolling
Updated: 11/30/2017
Coastal Clinical Research Inc
mi
from
Mobile, AL
Click here to add this to my saved trials
Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects
Open-Label, Multicenter Study Evaluating the Safety and Efficacy of the Nicotine Replacement Therapy Chrono Quit Smoking Solution (CQSS2) System (21mg) Compared to the NicoDerm® CQ® Patch (21mg) for Smoking Cessation in Treatment Seeking Subjects
Status: Enrolling
Updated:  11/30/2017
Clinical Research Consortium
mi
from
Tempe, AZ
Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects
Open-Label, Multicenter Study Evaluating the Safety and Efficacy of the Nicotine Replacement Therapy Chrono Quit Smoking Solution (CQSS2) System (21mg) Compared to the NicoDerm® CQ® Patch (21mg) for Smoking Cessation in Treatment Seeking Subjects
Status: Enrolling
Updated: 11/30/2017
Clinical Research Consortium
mi
from
Tempe, AZ
Click here to add this to my saved trials
Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects
Open-Label, Multicenter Study Evaluating the Safety and Efficacy of the Nicotine Replacement Therapy Chrono Quit Smoking Solution (CQSS2) System (21mg) Compared to the NicoDerm® CQ® Patch (21mg) for Smoking Cessation in Treatment Seeking Subjects
Status: Enrolling
Updated:  11/30/2017
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects
Open-Label, Multicenter Study Evaluating the Safety and Efficacy of the Nicotine Replacement Therapy Chrono Quit Smoking Solution (CQSS2) System (21mg) Compared to the NicoDerm® CQ® Patch (21mg) for Smoking Cessation in Treatment Seeking Subjects
Status: Enrolling
Updated: 11/30/2017
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Click here to add this to my saved trials
Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects
Open-Label, Multicenter Study Evaluating the Safety and Efficacy of the Nicotine Replacement Therapy Chrono Quit Smoking Solution (CQSS2) System (21mg) Compared to the NicoDerm® CQ® Patch (21mg) for Smoking Cessation in Treatment Seeking Subjects
Status: Enrolling
Updated:  11/30/2017
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects
Open-Label, Multicenter Study Evaluating the Safety and Efficacy of the Nicotine Replacement Therapy Chrono Quit Smoking Solution (CQSS2) System (21mg) Compared to the NicoDerm® CQ® Patch (21mg) for Smoking Cessation in Treatment Seeking Subjects
Status: Enrolling
Updated: 11/30/2017
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Click here to add this to my saved trials
Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects
Open-Label, Multicenter Study Evaluating the Safety and Efficacy of the Nicotine Replacement Therapy Chrono Quit Smoking Solution (CQSS2) System (21mg) Compared to the NicoDerm® CQ® Patch (21mg) for Smoking Cessation in Treatment Seeking Subjects
Status: Enrolling
Updated:  11/30/2017
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects
Open-Label, Multicenter Study Evaluating the Safety and Efficacy of the Nicotine Replacement Therapy Chrono Quit Smoking Solution (CQSS2) System (21mg) Compared to the NicoDerm® CQ® Patch (21mg) for Smoking Cessation in Treatment Seeking Subjects
Status: Enrolling
Updated: 11/30/2017
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
Human Laboratory Study Of Varenicline in Smokers
Human Laboratory Study Of Varenicline in Smokers
Status: Enrolling
Updated:  12/1/2017
Tobacco Use Research Center
mi
from
Minneapolis, MN
Human Laboratory Study Of Varenicline in Smokers
Human Laboratory Study Of Varenicline in Smokers
Status: Enrolling
Updated: 12/1/2017
Tobacco Use Research Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Pharmacokinetics of Nicotine Sublingual Tablets Versus Nicorette Lozenge in Healthy Smokers
An Open-Label Pseudorandomized, Two Way Crossover Comparison of the Single-Dose Pharmacokinetics of Nicotine 4 mg Sublingual Tablets Versus Nicorette Lozenge 4 mg in Healthy Smokers Under Fasted Conditions
Status: Enrolling
Updated:  12/1/2017
Rose Research Center, LLC
mi
from
Raleigh, NC
Pharmacokinetics of Nicotine Sublingual Tablets Versus Nicorette Lozenge in Healthy Smokers
An Open-Label Pseudorandomized, Two Way Crossover Comparison of the Single-Dose Pharmacokinetics of Nicotine 4 mg Sublingual Tablets Versus Nicorette Lozenge 4 mg in Healthy Smokers Under Fasted Conditions
Status: Enrolling
Updated: 12/1/2017
Rose Research Center, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Pilot Text Messaging Intervention to Reduce Smoking in Office-based Buprenorphine and Inpatient Detoxification Patients
Mobile Phone Messaging to Support Smoking Cessation Among Office-based Buprenorphine and Inpatient Detoxification Patients: a Pilot Study
Status: Enrolling
Updated:  12/4/2017
New York University School of Medicine
mi
from
New York, NY
A Pilot Text Messaging Intervention to Reduce Smoking in Office-based Buprenorphine and Inpatient Detoxification Patients
Mobile Phone Messaging to Support Smoking Cessation Among Office-based Buprenorphine and Inpatient Detoxification Patients: a Pilot Study
Status: Enrolling
Updated: 12/4/2017
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Investigation of the Impact of Smoking Status on Allergen-induced Nasal Airway Inflammation Using a Cat Hair (Felis Domesticus) Extract Nasal Allergen Challenge Model
Investigation of the Impact of Smoking Status on Allergen-induced Nasal Airway Inflammation Using a Cat Hair (Felis Domesticus) Extract Nasal Allergen Challenge Model
Status: Enrolling
Updated:  12/5/2017
UNC Center for Environmental Medicine, Asthma and Lung Biology
mi
from
Chapel Hill, NC
Investigation of the Impact of Smoking Status on Allergen-induced Nasal Airway Inflammation Using a Cat Hair (Felis Domesticus) Extract Nasal Allergen Challenge Model
Investigation of the Impact of Smoking Status on Allergen-induced Nasal Airway Inflammation Using a Cat Hair (Felis Domesticus) Extract Nasal Allergen Challenge Model
Status: Enrolling
Updated: 12/5/2017
UNC Center for Environmental Medicine, Asthma and Lung Biology
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women
Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women: Phase 1
Status: Enrolling
Updated:  12/15/2017
Alaska Native Tribal Health Consortium
mi
from
Anchorage, AK
Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women
Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women: Phase 1
Status: Enrolling
Updated: 12/15/2017
Alaska Native Tribal Health Consortium
mi
from
Anchorage, AK
Click here to add this to my saved trials
Biomarker Feedback to Motivate Tobacco Cessation in Pregnant ALaska Native Women: Phase 2
Biomarker Feedback to Motivate Tobacco Cessation in Pregnant ALaska Native Women: Phase 2
Status: Enrolling
Updated:  12/15/2017
Alaska Native Tribal Health Consortium
mi
from
Anchorage, AK
Biomarker Feedback to Motivate Tobacco Cessation in Pregnant ALaska Native Women: Phase 2
Biomarker Feedback to Motivate Tobacco Cessation in Pregnant ALaska Native Women: Phase 2
Status: Enrolling
Updated: 12/15/2017
Alaska Native Tribal Health Consortium
mi
from
Anchorage, AK
Click here to add this to my saved trials
Medicinal Nicotine for Preventing Cue Induced Craving
Status: Enrolling
Updated:  12/15/2017
Clinical and Translational Sciences Institute
mi
from
Minneapolis, MN
Medicinal Nicotine for Preventing Cue Induced Craving
Status: Enrolling
Updated: 12/15/2017
Clinical and Translational Sciences Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Biomarker Feedback to Motivate Cessation in Pregnancy
Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women (MAW) - Phase 3 Pilot Clinical Trial
Status: Enrolling
Updated:  12/15/2017
Alaska Native Tribal Health Consortium
mi
from
Anchorage, AK
Biomarker Feedback to Motivate Cessation in Pregnancy
Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women (MAW) - Phase 3 Pilot Clinical Trial
Status: Enrolling
Updated: 12/15/2017
Alaska Native Tribal Health Consortium
mi
from
Anchorage, AK
Click here to add this to my saved trials
Smoking Cessation for Smokers With Sleep Problems
Smoking Cessation for Smokers With Sleep Problems
Status: Enrolling
Updated:  12/20/2017
Yale University School of Medicine
mi
from
New Haven, CT
Smoking Cessation for Smokers With Sleep Problems
Smoking Cessation for Smokers With Sleep Problems
Status: Enrolling
Updated: 12/20/2017
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Smoking-induced EGF-dependent Reprogramming of Airway Basal Cell Function
Smoking-induced EGF-dependent Reprogramming of Airway Basal Cell Function
Status: Enrolling
Updated:  12/21/2017
Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine
mi
from
New York, NY
Smoking-induced EGF-dependent Reprogramming of Airway Basal Cell Function
Smoking-induced EGF-dependent Reprogramming of Airway Basal Cell Function
Status: Enrolling
Updated: 12/21/2017
Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Feasibility and Smokers' Reactions to DNA Feedback
Feasibility and Smokers' Reactions to DNA Feedback
Status: Enrolling
Updated:  1/4/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Feasibility and Smokers' Reactions to DNA Feedback
Feasibility and Smokers' Reactions to DNA Feedback
Status: Enrolling
Updated: 1/4/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
Status: Enrolling
Updated:  1/8/2018
Yale Center for Clinical Investigation and Yale Behavioral Pharmacology Laboratory
mi
from
New Haven, CT
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
Status: Enrolling
Updated: 1/8/2018
Yale Center for Clinical Investigation and Yale Behavioral Pharmacology Laboratory
mi
from
New Haven, CT
Click here to add this to my saved trials
Varenicline Treatment for Active Alcoholic Smokers
Varenicline Treatment for Active Alcoholic Smokers
Status: Enrolling
Updated:  1/9/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Varenicline Treatment for Active Alcoholic Smokers
Varenicline Treatment for Active Alcoholic Smokers
Status: Enrolling
Updated: 1/9/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Varenicline Treatment for Active Alcoholic Smokers
Varenicline Treatment for Active Alcoholic Smokers
Status: Enrolling
Updated:  1/9/2018
Franciscan Skemp Hospital
mi
from
La Crosse, WI
Varenicline Treatment for Active Alcoholic Smokers
Varenicline Treatment for Active Alcoholic Smokers
Status: Enrolling
Updated: 1/9/2018
Franciscan Skemp Hospital
mi
from
La Crosse, WI
Click here to add this to my saved trials
Contingency Management for Smoking Cessation in the Homeless
Contingency Management for Smoking Cessation in the Homeless
Status: Enrolling
Updated:  1/11/2018
The Friendship Center
mi
from
New Britain, CT
Contingency Management for Smoking Cessation in the Homeless
Contingency Management for Smoking Cessation in the Homeless
Status: Enrolling
Updated: 1/11/2018
The Friendship Center
mi
from
New Britain, CT
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
Celerion Arizona
mi
from
Tempe, AZ
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
Celerion Arizona
mi
from
Tempe, AZ
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
Clinical Research of West Florida
mi
from
Clearwater, FL
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
Clinical Research of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
Covance, Inc.
mi
from
Daytona Beach, FL
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
Covance, Inc.
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
Compass Research LLC
mi
from
Orlando, FL
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
Clinical Research of West Florida, Inc.
mi
from
Tampa, FL
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
Clinical Research of West Florida, Inc.
mi
from
Tampa, FL
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
Compass Research
mi
from
The Villages, FL
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
Compass Research
mi
from
The Villages, FL
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
Central Kentucky Research Associate
mi
from
Lexington, KY
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
Central Kentucky Research Associate
mi
from
Lexington, KY
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
Celerion Lincoln
mi
from
Lincoln, NE
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
Celerion Lincoln
mi
from
Lincoln, NE
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
PMG Research of Cary
mi
from
Cary, NC
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
PMG Research of Cary
mi
from
Cary, NC
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
Pmg Research Of Charlotte
mi
from
Charlotte, NC
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
Pmg Research Of Charlotte
mi
from
Charlotte, NC
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
PMG Research of Raleigh, LLC
mi
from
Raleigh, NC
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
PMG Research of Raleigh, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
PMG Research of Wilmington
mi
from
Wilmington, NC
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
PMG Research of Wilmington
mi
from
Wilmington, NC
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
PMG Research of Bristol, LLC
mi
from
Bristol, TN
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
PMG Research of Bristol, LLC
mi
from
Bristol, TN
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
NOCCR
mi
from
Knoxville, TN
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
NOCCR
mi
from
Knoxville, TN
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
Benchmark
mi
from
Austin, TX
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
Benchmark
mi
from
Austin, TX
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
Benchmark
mi
from
Fort Worth, TX
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
Benchmark
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
Benchmark
mi
from
San Angelo, TX
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
Benchmark
mi
from
San Angelo, TX
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
National Clinical Research, Inc.
mi
from
Richmond, VA
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
National Clinical Research, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated:  1/11/2018
Midwest Clinical Research
mi
from
Dayton, OH
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study
Status: Enrolling
Updated: 1/11/2018
Midwest Clinical Research
mi
from
Dayton, OH
Click here to add this to my saved trials
Contingency Management and Pharmacotherapy for Smoking Cessation
Contingency Management and Pharmacotherapy for Smoking Cessation
Status: Enrolling
Updated:  1/11/2018
University of Connecticut Health Center
mi
from
Farmington, CT
Contingency Management and Pharmacotherapy for Smoking Cessation
Contingency Management and Pharmacotherapy for Smoking Cessation
Status: Enrolling
Updated: 1/11/2018
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
Status: Enrolling
Updated:  1/12/2018
VA Connecticut Healthcare System
mi
from
West Haven, CT
Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
Status: Enrolling
Updated: 1/12/2018
VA Connecticut Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior
The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior
Status: Enrolling
Updated:  1/12/2018
Yale Center for Clinical Investigation, Yale University
mi
from
New Haven, CT
The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior
The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior
Status: Enrolling
Updated: 1/12/2018
Yale Center for Clinical Investigation, Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Progesterone for Smoking Relapse Prevention Following Delivery
Progesterone for Postpartum Smokers: Feasibility, Breastfeeding and Infant Safety
Status: Enrolling
Updated:  1/12/2018
Yale School of Medicine Dpt of Psychiatry
mi
from
New Haven, CT
Progesterone for Smoking Relapse Prevention Following Delivery
Progesterone for Postpartum Smokers: Feasibility, Breastfeeding and Infant Safety
Status: Enrolling
Updated: 1/12/2018
Yale School of Medicine Dpt of Psychiatry
mi
from
New Haven, CT
Click here to add this to my saved trials
Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers
Naltrexone and Varenicline: Weight Gain and Tolerability in Smokers
Status: Enrolling
Updated:  1/12/2018
Yale University School of Medicine Substance Abuse Treatment Unit
mi
from
New Haven, CT
Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers
Naltrexone and Varenicline: Weight Gain and Tolerability in Smokers
Status: Enrolling
Updated: 1/12/2018
Yale University School of Medicine Substance Abuse Treatment Unit
mi
from
New Haven, CT
Click here to add this to my saved trials
Adolescent Smoking Cessation in Pediatric Primary Care
Adolescent Smoking Cessation in Pediatric Primary Care
Status: Enrolling
Updated:  1/16/2018
American Academy of Pediatrics
mi
from
Elk Grove Village, IL
Adolescent Smoking Cessation in Pediatric Primary Care
Adolescent Smoking Cessation in Pediatric Primary Care
Status: Enrolling
Updated: 1/16/2018
American Academy of Pediatrics
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials